Skip to content
Investor Centre
  • Portal Access
  • Careers
  • Distributors
  • Australia
    • USA
    • EMEA
  • Log In
Genetic Signatures
  • Home
  • About Us
      • About Us

      • Genetic Signatures is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
        • Company Background
        • Our Technology
        • Our Facilities
        • Intellectual Property
        • Our Board
        • Our Principal Advisors
        • Executive Leadership Team
  • Our Products
  • Workflow
  • Media Centre
      • Media Centre

      • Genetic Signatures is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
      • All media
      • Blog
      • News
      • Events
      • Videos
      • Webinar
      • Publications, Articles & Presentations
  • Resources
  • Contact Us

Media Centre

Blog, News
November 11, 2025

A year of transformation and impact

Read more
Events
October 29, 2025

Annual General Meeting 2025

Read more
News
August 18, 2025

Welcoming our new CTO

Read more
News
August 25, 2025

2025 Annual Report

Read more
Videos
September 24, 2025

Molecular Testing for Intestinal Protozoa: How a Laboratory Developed Test Compares to One That Is FDA-Cleared

Read more
Videos
September 24, 2025

Implementation of pan-enteric PCR screening at a UK general district hospital – benefits, pitfalls and lessons learnt

Read more
Publications, Articles & Presentations
February 5, 2025

Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study

Read more
Publications, Articles & Presentations
August 30, 2025

Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia

Read more
Blog
June 2, 2025

Genetic Signatures Confirms Reliable Detection of Emerging COVID-19 Variant, NB.1.8.1

Read more
Blog
May 6, 2025

Laboratories urged to plan ahead as Australia anticipates another record-breaking respiratory season

Read more
News
November 22, 2024

Genetic Signatures 2024 AGM Highlights

Read more
News
September 24, 2024

A warm welcome to Allison Rossiter

Read more
Genetic Signatures Pty Ltd

Products & Technology

  • About Us
  • Our Products
  • Workflow
  • Media Centre
  • Contact Us

Investor Centre

  • Investors

Genetic Signatures was founded in 2001 by the late Dr. Geoffrey Grigg. We are the developers of 3base® technology which is the cornerstone of our EasyScreen™ Pathogen Detection Kits. Our proprietary technology provides hospital and pathology laboratories with the molecular tools to screen for a wide array of infectious pathogens.

Contact Us

Telephone
+61 2 9870 7580

Email
[email protected]

Follow Us

© 2025 Genetic Signatures. Terms & Conditions | Privacy Policy | Disclaimer

Our Address

Delivery Address
Genetic Signatures Ltd.
Heart Research Institute
7 Eliza Street Newtown,
NSW, 2042 Australia

Postal & Street Address
Genetic Signatures Ltd.
7 Eliza Street Newtown,
NSW, 2042 Australia

IMPORTANT Genetic Signatures' global website caters to a range of users from many jurisdictions and could contain information regarding products not available in all countries. Products shown here may have received approval or clearance by a governing regulatory body for different purposes in different jurisdictions. Genetic Signatures does not take any responsibility for accessing such information which may not comply with any law, regulation, registration or usage in the jurisdiction where the reader resides.

Genetic Signatures is an
ISO 13485 certified company

footer-iso-13485-logo

Website design & development by